Dividend Win Wednesday: 12% FCF Yields, $10M Insider Buys, and 20% Drawdowns

This Week's Setup

Dividend work this week spans miners, biotech, steel, defense, and specialty pharma, all with insider tickets and free cash yields that clear stated payouts by wide margins.

Newmont and Biogen anchor the precious metal and pharma cash machines, Nucor and Steel Dynamics add cyclical steel with insider accumulation, ConocoPhillips brings integrated energy cash conversion, General Dynamics adds defense order visibility on payout cover, and Viatris plus Gilead round out the list with FCF that still clears dividends.

The 8 Names

1. Newmont Corporation (NEM)

Stock Pixie Score 9.8/10 | FCF yield: 6.2% | Dividend yield: 1.0% | Payout cover: 6.5×

The FCF yield at 6.2% combines with a 29% ROIC and a 96-basis-point dividend to deliver a payout cover ratio of 6.5×, one of the cleanest in the gold space. Revenue growth last quarter came in at 21.3% year-over-year, and the company carries net cash, not debt, against EBITDA. Earnings yield sits at 5.9%, with a normalized P/E (10Y) of 16.9×, while the stock trades 20% below its 52-week high.

François Hardy, Mark Rodgers, and Natascha Viljoen all filed Form 4 buys in early March, adding $5.0 million in shares during the drawdown. The insider activity spans officers and directors, and net shares purchased in the last six months total 9,012 shares at a 2.3% buy-to-sell ratio.

Analyst consensus at $139.94 implies 29% upside, but gold equities carry operational risk in emerging jurisdictions and commodity price exposure outside management control.

2. Biogen Inc. (BIIB)

Stock Pixie Score 9.1/10 | FCF yield: 7.3% | Gross margin: 75.7% | Insider buy rate: 55.1%

The 7.3% FCF yield sits against a 75.7% gross margin, a return profile that generates significant shareholder value even without a stated dividend. ROIC clocks in at 6.8%, and revenue growth of 2.2% year-over-year signals stability in the product portfolio. The stock is down 9.5% from its 52-week high while insiders have added 83,809 net shares in the last six months.

Insider activity over the trailing half-year shows a 55.1% buy percentage versus 2.2% sell, with $7.7 million in net insider capital deployed. Oppenheimer raised its price target to $275 from $250 on March 28, and Canaccord lifted its target to $245 from $230, both maintaining buy-equivalent ratings.

Interest coverage of 6.8× and net debt at 0.79× EBITDA indicate moderate leverage, a constraint in a sector where balance-sheet flexibility matters for pipeline development.

Biotech carries binary event risk; pipeline data, FDA outcomes, and competitive dynamics can reprices the equity in a single session.

3. Nucor Corporation (NUE)

Stock Pixie Score 8.9/10 | Dividend yield: 1.3% | 5Y dividend CAGR: 6.5% | Insider net buy: $5.0M

The dividend yield of 1.3% combines with a 6.5% five-year growth rate and a 29.3% payout ratio, leaving meaningful room for continued increases. ROIC sits at 8.5%, and revenue growth of 5.7% year-over-year signals demand resilience despite steel sector headwinds. The stock is down 14% from its 52-week high, opening a moderate-dip entry.

Stephen Laxton, Leon Topalian, and John Sullivan all filed Form 4 purchases in mid-March, collectively adding $5.0 million in shares and 30,269 net shares in the last six months at a 1.4% buy-to-1.0% sell ratio. The activity spans the executive suite and board.

FCF yield prints negative at -0.5%, a function of elevated capital expenditure in the current cycle. The company is investing in capacity expansion, but free cash is temporarily constrained.

Steel pricing is cyclical and tied to construction, automotive, and infrastructure activity; a demand slowdown would compress margin and free cash flow generation.

4. Steel Dynamics, Inc. (STLD)

Stock Pixie Score 8.9/10 | Dividend yield: 1.1% | 5Y dividend CAGR: 14.9% | Shareholder yield: 3.5%

The 14.9% five-year dividend CAGR is one of the highest in the screen, and the 1.1% yield combines with a 2.4% total shareholder yield (dividends plus buybacks) to deliver capital return at 3.5%. ROIC of 9.8% and revenue growth of 3.6% year-over-year demonstrate operational efficiency. The stock is down 14% from its 52-week high, and the payout ratio sits at 24.8%, leaving ample coverage.

Barry Schneider filed two Form 4 buys in early and mid-March, and Christopher Graham added shares on March 13. Net insider buying in the last six months totals 192,897 shares with $5.1 million deployed, all buys, no sells.

Net debt sits at 1.78× EBITDA, the highest leverage ratio among the top four tickers. Interest coverage of 22.3× provides a buffer, but debt service becomes a consideration if EBITDA declines.

5. ConocoPhillips (COP)

Stock Pixie Score 8.8/10 | Dividend yield: 2.6% | FCF yield: 4.5% | ROIC: 13.4%

The 2.6% dividend yield pairs with a 4.5% FCF yield and a 13.4% ROIC, a combination that signals strong capital efficiency in the integrated energy space. Revenue growth of 7.7% year-over-year and a 25.1% gross margin keep the business model on track. The stock is down just 3.3% from its 52-week high, near all-time highs despite the broader market selloff.

José Mauricio Rodriguez Rios, Mauricio Botero Wolff, and Jaime Alberto Villegas Gutierrez all filed Form 4 buys on March 30, adding 372,839 net shares in the last six months with $7.1 million in insider capital deployed. The buy-to-sell ratio sits at 1.73% to 1.31%, indicating active accumulation.